Effects of vitamin D supplementation on interleukin-17 in children with nephrotic syndrome
Romanian Journal of Pediatrics · 30.06.2026 · 75 (2) · 83
DOI: 10.37897/rjp.2026.2.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Romanian Journal of Pediatrics, online erschienen am 30.06.2026. Verfasst von Ichsan Noor und 5 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background and objectives. Nephrotic syndrome (NS) is characterized by massive proteinuria, which may lead to urinary loss of vitamin D-binding protein and subsequent vitamin D deficiency. Vitamin D has immunomodulatory effects mediated through vitamin D receptor activation, including modulation of the T helper 17 (Th17) pathway and interleukin-17 (IL-17), a cytokine involved in podocyte injury and inflammation. This study evaluated the effects of two doses of vitamin D₃ supplementation on serum 25-hydroxyvitamin D [25(OH)D] and IL-17 levels in children with NS. Materials and methods. In this randomized, double-blind, controlled trial, children aged 1-18 years with NS were allocated to receive standard therapy plus oral vitamin D₃ at either 400 IU/day (Group I) or 1000 IU/day (Group II) for four weeks. Serum 25(OH)D and IL-17 concentrations were measured at baseline and after the intervention. Within-group and between-group analyses were performed to assess changes in these parameters.
Results
After four weeks, serum 25(OH)D levels increased significantly in both groups. The median increase was 4.7 ng/mL in Group I (p = 0.001) and 5.1 ng/mL in Group II (p = 0.018), with no significant difference between groups (p = 0.903). IL-17 levels decreased in both groups; however, these reductions were not statistically significant. The median change was −0.26 pg/mL in Group I (p = 0.057) and −0.18 pg/mL in Group II (p = 0.469), with no significant between-group difference (p = 0.682).
Conclusions
Vitamin D₃ supplementation at 400 IU/day and 1000 IU/day modestly increased serum 25(OH)D levels in children with NS but did not significantly reduce IL-17 levels over four weeks. The short intervention duration, relatively low supplementation doses, and persistent proteinuria may have limited the detectable immunomodulatory effects of vitamin D in this population.
Zitieren
APA
Noor, I., Jusli, J., Lawang, S. A., Febriani, A. D. B., Artati, R. D., & Urfianty, U. (2026). Effects of vitamin D supplementation on interleukin-17 in children with nephrotic syndrome. Romanian Journal of Pediatrics, 75(2), 83. https://doi.org/10.37897/rjp.2026.2.2
Vancouver
Noor I, Jusli J, Lawang SA, Febriani ADB, Artati RD, Urfianty U. Effects of vitamin D supplementation on interleukin-17 in children with nephrotic syndrome. Romanian Journal of Pediatrics. 2026;75(2):83. doi:10.37897/rjp.2026.2.2
BibTeX
@article{Noor2026,
author = {Noor, Ichsan and Jusli, Jusli and Lawang, St. Aizah and Febriani, A. Dwi Bahagia and Artati, Ratna Dewi and Urfianty, Urfianty},
title = {Effects of vitamin D supplementation on interleukin-17 in children with nephrotic syndrome},
journal = {Romanian Journal of Pediatrics},
year = {2026},
volume = {75},
number = {2},
pages = {83},
doi = {10.37897/rjp.2026.2.2}
}
EUVIMED